XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 5,713 $ 8,413
Trade accounts receivable, net of allowance for doubtful accounts of $303 and $346, respectively 27,779 20,232
Inventories, net 41,192 33,189
Prepaid expenses and other current assets 4,304 4,690
Total current assets 78,988 66,524
Property, plant and equipment, net 21,716 23,205
Goodwill 37,428 38,068
Other intangible assets, net 15,921 17,390
Deferred income taxes, net 12,069 11,472
Other noncurrent assets 2,308 2,879
Total assets 168,430 159,538
Current Liabilities:    
Accounts payable 16,074 9,823
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 2,890 1,842
Accrued expenses and other current liabilities 7,949 5,259
Total current liabilities 28,913 18,924
Long-term debt, net 19,310 18,857
Deferred income taxes 1,917 2,254
Other noncurrent liabilities 1,887 1,760
Total liabilities 52,027 41,795
Shareholders' Equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,570,710 shares and 20,522,427 shares, respectively;outstanding – 16,135,358 shares and 16,089,832 shares, respectively 2,057 2,052
Capital in excess of par value 187,405 186,518
Accumulated deficit (47,951) (47,832)
Accumulated other comprehensive loss (3,750) (1,653)
Treasury stock - at cost; 4,435,352 shares and 4,432,595 shares, respectively 21,484 21,469
Total Ultralife Corporation equity 116,277 117,616
Non-controlling interest 126 127
Total shareholders’ equity 116,403 117,743
Total liabilities and shareholders' equity $ 168,430 $ 159,538